Have a feature idea you'd love to see implemented?
Let us know!
Price (delayed)
$60.49
Market cap
$9.16B
P/E Ratio
25.1
Dividend/share
$0.2
EPS
$2.41
Enterprise value
$11.26B
Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker's high-performance scienti c instruments and high-value analytical and diagnostic solutions
Highlights
BRKR's equity is up by 45% YoY and by 26% QoQ
BRKR's price to earnings (P/E) is 33% lower than its 5-year quarterly average of 37.2 and 12% lower than its last 4 quarters average of 28.6
BRKR's EPS is down by 12% since the previous quarter but it is up by 11% year-on-year
The net income has declined by 12% since the previous quarter but it is up by 10% year-on-year
Bruker's debt has soared by 83% YoY and by 55% from the previous quarter
The quick ratio has decreased by 40% YoY and by 24% from the previous quarter
Key stats
What are the main financial stats of BRKR
Market
Valuations
Earnings
Shares outstanding
151.39M
Market cap
$9.16B
Enterprise value
$11.26B
Price to book (P/B)
4.91
Price to sales (P/S)
2.86
EV/EBIT
24.69
EV/EBITDA
18.77
EV/Sales
3.61
Revenue
$3.12B
EBIT
$455.9M
EBITDA
$599.7M
Free cash flow
$169.4M
Per share
Balance sheet
Liquidity
EPS
$2.41
Free cash flow per share
$1.15
Book value per share
$12.31
Revenue per share
$21.16
TBVPS
$23.3
Total assets
$5.9B
Total liabilities
$4.08B
Debt
$2.27B
Equity
$1.79B
Working capital
$848.5M
Debt to equity
1.27
Current ratio
1.65
Quick ratio
0.59
Net debt/EBITDA
3.5
Margins
Efficiency
Dividend
EBITDA margin
19.2%
Gross margin
49.7%
Net margin
11.3%
Operating margin
10.9%
Return on assets
7.6%
Return on equity
24.3%
Return on invested capital
13.8%
Return on capital employed
9.9%
Return on sales
14.6%
Dividend yield
0.33%
DPS
$0.2
Payout ratio
8.3%
BRKR stock price
How has the Bruker stock price performed over time
Intraday
-1.27%
1 week
-5.08%
1 month
-6.98%
1 year
-3.48%
YTD
-17.68%
QTD
-12.41%
Financial performance
How have Bruker's revenue and profit performed over time
Revenue
$3.12B
Gross profit
$1.55B
Operating income
$340.9M
Net income
$352.1M
Gross margin
49.7%
Net margin
11.3%
BRKR's operating margin is down by 37% YoY and by 13% QoQ
BRKR's operating income is down by 28% year-on-year and by 10% since the previous quarter
Bruker's net margin has decreased by 16% from the previous quarter and by 4.2% YoY
Bruker's revenue has increased by 15% YoY and by 4% QoQ
Growth
What is Bruker's growth rate over time
Valuation
What is Bruker stock price valuation
P/E
25.1
P/B
4.91
P/S
2.86
EV/EBIT
24.69
EV/EBITDA
18.77
EV/Sales
3.61
BRKR's price to earnings (P/E) is 33% lower than its 5-year quarterly average of 37.2 and 12% lower than its last 4 quarters average of 28.6
BRKR's EPS is down by 12% since the previous quarter but it is up by 11% year-on-year
BRKR's equity is up by 45% YoY and by 26% QoQ
The stock's price to book (P/B) is 44% less than its 5-year quarterly average of 8.7 and 33% less than its last 4 quarters average of 7.3
The stock's price to sales (P/S) is 27% less than its 5-year quarterly average of 3.9 and 21% less than its last 4 quarters average of 3.6
Bruker's revenue has increased by 15% YoY and by 4% QoQ
Efficiency
How efficient is Bruker business performance
BRKR's return on assets is down by 22% since the previous quarter and by 14% year-on-year
Bruker's return on invested capital has decreased by 21% QoQ and by 19% YoY
Bruker's return on equity has decreased by 21% QoQ and by 15% YoY
BRKR's return on sales is down by 14% since the previous quarter and by 9% year-on-year
Dividends
What is BRKR's dividend history
DPS
$0.2
Dividend yield
0.33%
Payout ratio
8.3%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Bruker financials performed over time
BRKR's total assets is 45% greater than its total liabilities
BRKR's total liabilities has soared by 56% YoY and by 33% QoQ
BRKR's total assets has surged by 53% year-on-year and by 31% since the previous quarter
Bruker's debt is 27% more than its equity
Bruker's debt has soared by 83% YoY and by 55% from the previous quarter
BRKR's equity is up by 45% YoY and by 26% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.